Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies
NCT02222545
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
58
Enrollment
INDUSTRY
Sponsor class
Conditions
Thrombotic Microangiopathies
Interventions
BIOLOGICAL:
OMS721
Sponsor
Omeros Corporation